The first four patient procedures were performed by Principal Investigator Professor Mattias Duytschaever, M.D., at Sint-Jan Hospital in Brugge, Belgium.
"We are very pleased with the progress of our First-In-Man clinical study and we look forward to the forthcoming studies for our technology in the European markets" said Randy Werneth, CEO/president. "We have the ability in a matter of seconds to generate real-time 3-D images of the heart with quality equivalent to a CT or MRI."
Since June, 2011, Acutus Medical has pioneered a new approach in the minimally invasive imaging and mapping of cardiac arrhythmias. The company has concentrated its efforts on the developing its technology for the treatment of an aberrant arrhythmia, atrial fibrillation (AF). Acutus Medical believes that its technology may eventually play a significant role in improving the lives of countless individuals who are afflicted by AF.
For more information: www.acutusmedical.com